The influence of intermittent bretylium tosylate (darenthin) on the development of vascular disease in rats with hypertension caused by sodium retention.
GARDNER
D L
DL
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001808:Blood Vessels; D001950:Bretylium Tosylate; D004194:Disease; D006955:Hypernatremia; D006973:Hypertension; D051381:Rats; D012964:Sodium / Q000378:metabolism*; D014652:Vascular Diseases
D000959:Antihypertensive Agents; D001950:Bretylium Tosylate; D012964:Sodium
ANTIHYPERTENSIVE AGENTS/pharmacology; BLOOD VESSELS/diseases; HYPERTENSION/experimental; SODIUM/metabolism